( OTC-PINK:CBMG,OTC-QB:CBMG )

News from cellular biomedicine group A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Dec 13, 2013, 15:33 ET Cellular Biomedicine Group Announces Completion of Patient Treatment for Phase I Clinical Trial for Liver Cancer

Cellular Biomedicine Group, Inc. (OTCQB: CBMG),  a biomedicine firm engaged in the development of new treatments for degenerative and...


Nov 09, 2013, 05:55 ET Cellular Biomedicine Group Announces Adjournment of Its Annual Shareholder Meeting

 Cellular Biomedicine Group, Inc. (OTCQB: CBMG) today convened the annual meeting of its shareholders. Because a quorum was not achieved by...


Nov 07, 2013, 14:45 ET Cellular Biomedicine Group Announces November 07, 2013 as Voting Deadline for Its Annual Shareholder Meeting

 Cellular Biomedicine Group, Inc. (OTCQB: CBMG) today reminded all its shareholders that the Board of the Company has set November 08, 2013 as...


Nov 05, 2013, 11:36 ET Cellular Biomedicine Group Receives Approval for Phase IIb Clinical Trial of ReJoin™ for Treatment of Knee Osteoarthritis (KOA)

 Cellular Biomedicine Group, Inc. (OTCQB: CBMG), a biomedicine firm engaged in the development of new treatments for degenerative and cancerous...


Nov 01, 2013, 10:01 ET Cellular Biomedicine Group Announces Completion of Patient Treatment for Phase I/IIa Clinical Trial for Treatment of Knee Osteoarthritis (KOA)

Cellular Biomedicine Group, Inc. (OTCQB: CBMG) is pleased to announce that it has treated the final patient of its Phase I/IIa clinical trial for...


Oct 30, 2013, 09:01 ET Cellular Biomedicine Group Announces New Product Approved for Market in China and New Exclusive License

Today Cellular Biomedicine Group (OTCQB:CBMG) announced that their A-Stromal™ adipose stromal cell purification kit is ready to launch on the...


Oct 25, 2013, 10:08 ET Cellular Biomedicine Group calls for General Annual Shareholder Meeting on November 08, 2013

 Cellular Biomedicine Group, Inc. (OTCQB:CBMG) today announced that the Board of the Company has set November 08, 2013 as the date for the...


Oct 14, 2013, 09:44 ET Cellular Biomedicine Group Appoints Three Independent Directors to the Board

Cellular Biomedicine Group, Inc. (OTCQB: CBMG) today announced that the Board of the Company has appointed three new independent directors to the...


Oct 01, 2013, 07:50 ET Cellular Biomedicine Group Announces Appointment of New CEO

 Cellular Biomedicine Group, Inc. (OTCQB: CBMG) announced today that it has promoted Dr. Wei (William) Cao to serve as its Chief Executive...


Sep 11, 2013, 09:28 ET Cellular Biomedicine Group Announces Change of Auditor

Cellular Biomedicine Group, Inc. (OTCQB: CBMG), a biomedicine firm engaged in the development of new treatments for degenerative and...


Sep 06, 2013, 07:00 ET Cellular Biomedicine Group Announces Positive Interim Results from Phase I/IIa Clinical Trial for Treatment of Knee Osteoarthritis (KOA)

 Cellular Biomedicine Group, Inc. (OTCQB: CBMG) today announced the interim results of its Phase I/IIa clinical trial for human adipose-derived...


Aug 22, 2013, 11:48 ET Cellular Biomedicine Group Announces Completion of Patient Enrollment for Phase I Clinical Trial for Liver Cancer

 Cellular Biomedicine Group (OTCQB: CBMG) today announced that it has completed patient enrollment for its Phase I trial to evaluate the safety...


Aug 16, 2013, 11:17 ET Cellular Biomedicine Group Reports Second Quarter and First Half 2013 Financial Results and Business Highlights

 Cellular Biomedicine Group, Inc. (OTCQB: CBMG), a developer of proprietary cell therapies for the treatment of degenerative diseases and...


Jul 22, 2013, 10:25 ET Cellular Biomedicine Group Completes Enrollment in Phase I Clinical Trial for Knee Osteoarthritis

Cellular Biomedicine Group (OTCQB:CBMG) today announced that it has completed the enrollment required for its Phase I trial to evaluate the safety...


Jul 11, 2013, 14:39 ET Cellular Biomedicine Group Appoints Director of Medical Research

 Cellular Biomedicine Group, Inc. (OTCQB: CBMG), a biomedicine firm engaged in the development of new treatments for degenerative and cancerous...


Jun 13, 2013, 07:18 ET Cellular Biomedicine Group Announces Expansion in the Osteoarthritis and Rheumatoid Arthritis Market

Cellular Biomedicine Group, Inc. (OTCQB: CBMG), a biomedicine firm engaged in the development of new treatments for degenerative and cancerous...


Jun 06, 2013, 07:58 ET Cellular Biomedicine Group Announces Appointment of Corporate Controller

Cellular Biomedicine Group, Inc. (OTCQB:CBMG), a biomedicine firm engaged in the development of new treatments for degenerative and cancerous...


May 22, 2013, 08:01 ET Cellular Biomedicine Group Announces Enrollment Milestone for Phase I Clinical Trial for Liver Cancer

Cellular Biomedicine Group (OTCQB: CBMG) today announced that it has achieved half of the enrollment of the total projected enrollment required for...


May 17, 2013, 08:44 ET Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis

 Cellular Biomedicine Group (OTCQB: CBMG) today announced that it has achieved 50% enrollment of the total projected enrollment required for...


Apr 25, 2013, 07:16 ET Cellular Biomedicine Group Provides Update and 2013 Milestones

 Cellular Biomedicine Group, Inc. (CBMG), a developer of proprietary cell therapies for the treatment of degenerative diseases and cancers,...


Apr 03, 2013, 09:06 ET Cellular Biomedicine Group Marks the Launch of Clinical Trial for Knee Osteoarthritis (KOA)

 This week Cellular Biomedicine Group (OTCQB: CBMG) held a ceremony to mark the launch of their clinical trial for haMPC (Human Adipose-derived...


Mar 21, 2013, 07:35 ET Cellular Biomedicine Group Marks the Launch of China Clinical Trial for TC-DC Therapy for Hepatocellular Carcinoma

Cellular Biomedicine Group (OTCQB: CBMG) announced that in the first week of March 2013, the company launched a clinical trial for TC-DC...


Mar 14, 2013, 08:33 ET Cellular Biomedicine Group Appoints Dr. Jianping Dai to the Board of Directors

Cellular Biomedicine Group Inc. (OTCQB:CBMG) today announced the appointment of Dr. Jianping Dai to the Board of Directors. Dr. Dai is a...


Feb 22, 2013, 08:23 ET Cellular Biomedicine Group President Presents Keynote Address at New York Stem Cell Summit

 Dr Wei William Cao, PhD, BM, President of Cellular Biomedicine Group presented a keynote address at the 8th annual New York Stem Cell Summit...


Feb 21, 2013, 08:40 ET Cellular Biomedicine Group Announces Selection of Audit Committee Chairman

 Cellular Biomedicine Group (incorporated as EastBridge Investment Group Corp. (OTCQB: EBIGD)) today announced the selection of Tony Liu...